Health Catalyst
HCAT
128 hedge funds and large institutions have $991M invested in Health Catalyst in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 65 increasing their positions, 17 reducing their positions, and 15 closing their positions.
282% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 17
219% more call options, than puts
Call options by funds: $2.61M | Put options by funds: $816K
133% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 15
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
47% more capital invested
Capital invested by funds: $675M → $991M (+$316M)
20.12% more ownership
Funds ownership: 69.28% → 89.39% (+20%)
19% more funds holding
Funds holding: 108 → 128 (+20)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NVPX
Norwest Venture Partners XII
Palo Alto,
California
|
+$65M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$42M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$35.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.3M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$22.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SUT
SC US (TTGP)
Menlo Park,
California
|
-$80.8M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$28.5M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$16.9M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.3M |
| 5 |
JP Morgan Chase
New York
|
-$5.2M |
HCAT Hedge Fund Activity: Q2 2020 in Review
128 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q2 2020, worth a combined $991M — up 47% from $675M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new HCAT positions and 15 closed out — a net gain of 20 holders — while 65 added to existing stakes and 17 trimmed.
The largest buyer was Norwest Venture Partners XII, opening a new position worth an estimated $65M. The largest seller was SC US (TTGP), exiting entirely with an estimated $80.8M sold.
- 128 institutional investors held Health Catalyst (HCAT) as of Q2 2020, up from 108 in Q1 2020.
- Funds reported $991M of Health Catalyst stock for Q2 2020, up 47% quarter-over-quarter.
- 35 funds opened new Health Catalyst positions in Q2 2020 and 15 closed out, a net change of +20 holders.
- The largest Health Catalyst buyer in Q2 2020 was Norwest Venture Partners XII, an estimated $65M added.
- The largest Health Catalyst seller in Q2 2020 was SC US (TTGP), an estimated $80.8M sold.
Based on aggregated 13F filings for Q2 2020.